Polycystic Ovary Syndrome Is Associated With Endothelial Dysfunction

Background —We recently reported endothelial dysfunction as a novel cardiovascular risk factor associated with insulin resistance/obesity. Here, we tested whether hyperandrogenic insulin-resistant women with polycystic ovary syndrome (PCOS) who are at increased risk of macrovascular disease display impaired endothelium-dependent vasodilation and whether endothelial function in PCOS is associated with particular metabolic and/or hormonal characteristics. Methods and Results —We studied leg blood flow (LBF) responses to graded intrafemoral artery infusions of the endothelium-dependent vasodilator methacholine chloride (MCh) and to euglycemic hyperinsulinemia in 12 obese women with PCOS and in 13 healthy age- and weight-matched control subjects (OBW). LBF increments in response to MCh were 50% lower in the PCOS group than in the OBW group (P <0.01). Euglycemic hyperinsulinemia increased LBF above baseline by 30% in the PCOS and 60% in OBW group (P <0.05 between groups). Across all subjects, the maximal LBF response to MCh exhibited a strong inverse correlation with free testosterone levels (r =−0.52, P <0.007). This relationship was stronger than with any other parameter, including insulin sensitivity. Conclusions —PCOS is characterized by (1) endothelial dysfunction and (2) resistance to the vasodilating action of insulin. This endothelial dysfunction appears to be associated with both elevated androgen levels and insulin resistance. Given the central vasoprotective role of endothelium, these findings could explain, at least in part, the increased risk for macrovascular disease in women with PCOS.

[1]  A. Dunaif,et al.  The independent effects of hyperandrogenaemia, hyperinsulinaemia, and obesity on lipid and lipoprotein profiles in women. , 1990, Clinical endocrinology.

[2]  L. Kuller,et al.  Coronary heart disease risk factors in women with polycystic ovary syndrome. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[3]  Y. Ouchi,et al.  The impairment of flow-mediated vasodilatation in obese men with visceral fat accumulation , 1998, International Journal of Obesity.

[4]  S. Moncada,et al.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.

[5]  Y. Ouchi,et al.  Modulation of endothelium-dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle. , 1995, Circulation.

[6]  A. Baron,et al.  Type II diabetes abrogates sex differences in endothelial function in premenopausal women. , 2000, Circulation.

[7]  J. Crave,et al.  Pathophysiology of sex hormone binding globulin (SHBG): Relation to insulin , 1991, The Journal of Steroid Biochemistry and Molecular Biology.

[8]  A. Baron,et al.  Insulin-mediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsiveness in lean humans. , 1995, The Journal of clinical investigation.

[9]  A. Avignon,et al.  Relationship between insulin sensitivity, obesity, body fat distribution and β-endorphinaemia in obese women , 1998, International Journal of Obesity.

[10]  A. Dunaif,et al.  Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. , 1997, Endocrine reviews.

[11]  K. Kugiyama,et al.  Gender difference in improvement of endothelium-dependent vasodilation after estrogen supplementation. , 1997, Journal of the American College of Cardiology.

[12]  A. Baron,et al.  Endothelial function, insulin sensitivity, and hypertension. , 1997, Circulation.

[13]  Baron Ad,et al.  Endothelial function, insulin sensitivity, and hypertension. , 1997 .

[14]  W. Kannel,et al.  Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. , 1986, American heart journal.

[15]  河野 宏明.  Gender difference in improvement of endothelium-dependent vasodilation after estrogen supplementation , 1999 .

[16]  S. Franks,et al.  Sex hormone-binding globulin and female reproductive function , 1995, The Journal of Steroid Biochemistry and Molecular Biology.

[17]  Stamatis Adamopoulos,et al.  17β-Estradiol Attenuates Acetylcholine-Induced Coronary Arterial Constriction in Women but Not Men With Coronary Heart Disease , 1995 .

[18]  A. Whittemore,et al.  Menopause and the risk of coronary heart disease in women. , 1987, The New England journal of medicine.

[19]  J. Cooke,et al.  L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. , 1992, The Journal of clinical investigation.

[20]  R. Pasquali,et al.  Weight control and its beneficial effect on fertility in women with obesity and polycystic ovary syndrome. , 1997, Human reproduction.

[21]  M. Laakso,et al.  Kinetics of In Vivo Muscle Insulin-Mediated Glucose Uptake in Human Obesity , 1990, Diabetes.

[22]  M. Frölich,et al.  Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM , 1997, Diabetologia.

[23]  D. Celermajer,et al.  Androgen deprivation is associated with enhanced endothelium-dependent dilatation in adult men. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[24]  K. Polonsky,et al.  Troglitazone Improves Defects in Insulin Action , Insulin Secretion , Ovarian Steroidogenesis , and Fibrinolysis in Women with Polycystic Ovary Syndrome * , 1997 .

[25]  H. White,et al.  Association between Polycystic Ovaries and Extent of Coronary Artery Disease in Women Having Cardiac Catheterization , 1997, Annals of Internal Medicine.

[26]  A. Baron,et al.  Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans. , 1988, The American journal of physiology.

[27]  J. Connell,et al.  INSULIN AS A VASCULAR HORMONE: IMPLICATIONS FOR THE PATHOPHYSIOLOGY OF CARDIOVASCULAR DISEASE , 1998, Clinical and experimental pharmacology & physiology.

[28]  K. Elkind-Hirsch,et al.  Intravenous glucose tolerance test-derived insulin sensitivity changes during the menstrual cycle. , 1991, The Journal of clinical endocrinology and metabolism.

[29]  A. Baron,et al.  Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. , 1996, The Journal of clinical investigation.

[30]  K. Segal,et al.  Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome , 1989, Diabetes.

[31]  B. Grubb,et al.  Clinical signs of androgen excess as risk factors for coronary artery disease. , 1990, Fertility and sterility.

[32]  S. Haffner,et al.  The relationship of sex hormones to hyperinsulinemia and hyperglycemia. , 1988, Metabolism: clinical and experimental.

[33]  A. Quyyumi,et al.  Effect of Increased Availability of Endothelium‐Derived Nitric Oxide Precursor on Endothelium‐Dependent Vascular Relaxation in Normal Subjects and in Patients With Essential Hypertension , 1993, Circulation.

[34]  A. Sevanian,et al.  Cardioprotective effects of individual conjugated equine estrogens through their possible modulation of insulin resistance and oxidation of low-density lipoprotein. , 1997, Fertility and sterility.

[35]  P. Ganz,et al.  Estrogen Improves Endothelium-Dependent, Flow-Mediated Vasodilation in Postmenopausal Women , 1994, Annals of Internal Medicine.